Guarnieri Anna, Mallamaci Rosanna, Trapani Giuseppe, Ianniciello Dolores, Scieuzo Carmen, Iannielli Francesco, Capasso Luigi, Sportelli Maria Chiara, Barbanente Alessandra, Marsico Michela, De Bonis Angela, Castellani Stefano, Falabella Patrizia, Trapani Adriana
Department of Basic and Applied Sciences, University of Basilicata, 85100 Potenza, Italy.
Department of Biosciences, Biotechnologies and Environment, University of Bari "Aldo Moro", 70125 Bari, Italy.
Pharmaceutics. 2025 Aug 5;17(8):1016. doi: 10.3390/pharmaceutics17081016.
. Larvae of the insect can represent an alternative source for low-molecular-weight chitosan (CS) production compared with CS from crustaceans (CS), making it appealing in terms of pharmaceutical applications. Hence, the performances of CS and CS were compared herein by investigating the in vitro features of nanoparticles (NPs) made from each polysaccharide and administered with the antioxidant quercetin (QUE). . X-ray diffraction and FT-IR spectroscopy enabled the identification of each type of CS. Following the ionic gelation technique and using sulfobutylether-β-cyclodextrin as a cross-linking agent, NPs were easily obtained. Physicochemical data, release studies in PBS, and the evaluation of antioxidant effects via the 1,1-diphenyl-2-picrylhydrazyl (DPPH) test were studied for both CS and CS. QUE-loaded NP sizes ranged from 180 to 547 nm, and zeta potential values were between +7.5 and +39.3 mV. In vitro QUE release in PBS was faster from QUE-CS NPs than from CS, and high antioxidant activity-according to the DPPH test-was observed for all tested NP formulations. The agar diffusion assay, referring to and as well as the microdilution assay, showed the best performance as antimicrobial formulations in the case of QUE-CS NPs. QUE-CS NPs can represent a promising vehicle for QUE, releasing it in a sustained manner, and, relevantly, the synergism noticed between QUE and CS resulted in a final antimicrobial product. New perspectives for low-molecular-weight CS are disclosed by adopting renewable sources from insects instead of the commercial CS
与来自甲壳类动物的壳聚糖(CS)相比,这种昆虫的幼虫可成为生产低分子量壳聚糖(CS)的另一种来源,这使其在药物应用方面具有吸引力。因此,本文通过研究由每种多糖制成并与抗氧化剂槲皮素(QUE)一起给药的纳米颗粒(NPs)的体外特性,比较了CS和CS的性能。X射线衍射和傅里叶变换红外光谱能够鉴定每种类型的CS。采用离子凝胶化技术并使用磺丁基醚-β-环糊精作为交联剂,很容易获得纳米颗粒。对CS和CS都研究了物理化学数据、在磷酸盐缓冲盐溶液中的释放研究以及通过1,1-二苯基-2-苦基肼(DPPH)试验评估抗氧化作用。负载QUE的纳米颗粒尺寸范围为180至547nm,zeta电位值在+7.5至+39.3mV之间。在磷酸盐缓冲盐溶液中,QUE从QUE-CS纳米颗粒中的体外释放比从CS中更快,并且根据DPPH试验,所有测试的纳米颗粒制剂都具有高抗氧化活性。琼脂扩散试验(参考 和 )以及微量稀释试验表明,在QUE-CS纳米颗粒的情况下,其作为抗菌制剂表现最佳。QUE-CS纳米颗粒可以成为QUE的一种有前途的载体,以持续的方式释放它,并且相关地,QUE和CS之间的协同作用产生了最终的抗菌产品。通过采用来自昆虫的可再生来源而不是商业CS,揭示了低分子量CS的新前景